Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils ...

Dupixent approved as the first-ever biologic medicine in Japan for patients with COPDFollowing recent approvals in the EU, China, and the US, ...

Nvidia (NASDAQ:NVDA) has kicked off 2025 in muted fashion. Unlike the strong momentum seen over the past couple of years, the ...

Kyndryl Holdings (KD) is down -12.4%, or -$4.21 to $29.85.Light Up your Portfolio with Spark:Easily identify stocks' risks and opportunities.

The stock of AppLovin (APP) is down 20% as a third short seller raises concerns about the company’s digital advertising ...

Shares of AI chatbot company Verint Systems (VRNT) dived over 10% on Thursday to touch its lowest level in a year after the ...

OpenAI released its new 4o Image Generation feature in ChatGPT, and it has become so popular that the company is temporarily ...

Novo Nordisk’s (NVO) stock has dropped by 25% in March (on the Copenhagen exchange) to put it on track for its biggest ...

Philip Morris (PM) wants to convert customers to heated tobacco products with a new launch in Texas. The tobacco company has ...

OpenAI is expecting a monster 2025. The Sam Altman-led firm now projects $12.7 billion in revenue this year—nearly triple ...

Executives from America’s largest oil companies aren’t holding back in a new survey, venting their frustration over what they ...

A new rumor emerged recently that may, if it comes to pass, light a fire under chip stock Intel (INTC) and its foundry ...